Oral Presentation

C. Friedrich, V. Hurez, R. Myers, M. Reed, K. Dasika, K. Kudrycki, R. Sheehan, T. Zhang, G. Gauderat, A. Aussy, L. Chadli, F. Chassereau, S. Fouliard, S. Hubert, E. Desvaux, P. Soret, L. Laigle, P. Moingeon

Predicted efficacy of a pan neutralizing anti interferon-alpha (IFN-α) monoclonal antibody in a virtual systemic lupus erythematosus (SLE) patient cohort using a mechanistic SLE PhysioPD QSP model

Presented by Servier and Rosa at the Quantitative Systems Pharmacology Conference 2022 (QSPC2022), April 2022,

Poster

C. Friedrich, V. Hurez, R. Myers, M. Reed, K. Dasika, K. Kudrycki, R. Sheehan, T. Zhang, G. Gauderat, A. Aussy, L. Chadli, F. Chassereau, S. Fouliard, S. Hubert, E. Desvaux, P. Soret, L. Laigle, P. Moingeon

Predicted efficacy of a pan neutralizing anti interferon-alpha (IFN-α) monoclonal antibody in a virtual systemic lupus erythematosus (SLE) patient cohort using a mechanistic SLE PhysioPD QSP model.

Presented by Servier and Rosa at the Quantitative Systems Pharmacology Conference 2022 (QSPC2022), April 2022,

White Paper

William C. Brastow, PhD

Commercializing Life Science Products

Which Product Properties Are Important in Convincing Physicians and Patients to Use My Product? And How to Ask This Question.

"We enable our clients to learn things that would be impractical or impossible to learn from empirical studies alone."
—Mike Reed, PhD, Chief Scientist, PhysioPD
Learn more about PhysioPD